DNA Gyrase-IN-18
DNA Gyrase-IN-18 (Compound 6B) is a DNA Gyrase inhibitor and Antibacterial agent. DNA Gyrase-IN-18 significantly inhibits the supercoiling activity of DNA Gyrase. DNA Gyrase-IN-18 inhibits biofilm formation by *Staphylococcus aureus*. DNA Gyrase-IN-18 exhibits excellent antibacterial activity, with a MIC of 0.125 μg/mL against Staphylococcus aureus and a MIC of 0.5 μg/mL against Mycobacterium tuberculosis.
For research use only. We do not sell to patients.
- Formula: C20H16BrN5O
- Molecular Weight:422.28
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Topoisomerase Isoforms
More
Biological Activity
DNA Gyrase-IN-18 (0.03-64 μg/mL; 18-24 h) potently inhibits growth of Staphylococcus aureus (ATCC 29213) with a MIC of 0.125 μg/mL after 18-24 h incubation at 37 °C[1].
DNA Gyrase-IN-18 (0.03-64 μg/mL; 7 days) potently inhibits growth of Mycobacterium tuberculosis (MC 26230) with a MIC of 0.5 μg/mL after 7 days incubation at 37 °C[1].
DNA Gyrase-IN-18 (0.19-200 μg/mL; 24 h) shows low cytotoxicity against HepG2 cells with a CC50 of 103.6 μg/mL, yielding a high selectivity index of 828.8 for Staphylococcus aureus (ATCC 29213)[1].
DNA Gyrase-IN-18 (0.25-128 μg/mL; 48 h) inhibits biofilm formation by Staphylococcus aureus (ATCC 29213) with an MBIC50 of 0.309 μg/mL after 48 h static incubation at 37 °C[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Molecular Weight 422.28
-
Formula C20H16BrN5O
-
SMILES
O=C(N/N=C\C1=CNC2=C1C=CC=C2)CN3C=CC(C4=CC=C(C=C4)Br)=N3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)